Anupam Rasayan India (ANURAS) — Announcement

📢 Key Event
Crisil reaffirms Anupam Rasayan's ratings with Watch Developing status

🔄 What Changed
Operating margin declined to 22.19% from 27.67% in fiscal 2025

🔮 What's Next
Watch Developing status indicates ongoing evaluation

💡 Investor Takeaway
The rating watch signals acquisition-related risks that could affect future stability

Anupam Rasayan India Ltd received a Crisil credit rating reaffirmation with a 'Watch Developing' status, highlighting risks from its pending Bliss GVS Pharma acquisition funded partly by debt and equity, while noting strong market position and improved working capital metrics; revenue rose to ₹2,365 crores in fiscal 2026 from ₹1,439 crores in 2025, though operating margins declined to 22.19% from 27.67%.

📄 View Original Announcement (PDF)

📊 Stock Analysis — ANURAS ✨ Ask AI About This

About Anupam Rasayan India Ltd (ANURAS)

Chemicals · Chemicals · Listed on BSE

Market Cap: ₹14,369.93 Cr P/E: 82.1 ROE: 8.2% ROCE: 10.4% Div Yield: 0.12%

View full ANURAS stock details →

📡 Get AI alerts when ANURAS files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track ANURAS — Free

💡 Ask AI about this filing

"How will the Bliss GVS Pharma acquisition impact profitability?" "What is the expected timeline for debt reduction post-acquisition?" "How does the rating watch affect potential equity dilution from funding?"

Ask AI Free →

📊 More ANURAS filings

See all ANURAS filings →

🔥 Also filed on 31 August 2026

ARKADE Arkade Developers Ltd Annual Report DCBBANK DCB Bank Ltd Corporate Action HIKAL Hikal Ltd Annual Report 514470 Winsome Textile Industries Ltd Annual Report 523896 AVI Products India Ltd Annual Report JKIL J Kumar Infraprojects Ltd Annual Report

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when ANURAS files new disclosures

Track ANURAS filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track ANURAS — Free

Free account · 2 AI queries/day

About · Privacy Policy · Terms of Service · Pricing

Today's Announcements · Screener · Insights · AI Chat

Data provided by CMOTS Internet Technologies Pvt Ltd